Quantcast

Optima Neuroscience, Inc., an Alachua-based UF licensee focused on the development of brain monitoring technologies, announced the close of a Series A financing round. The funding, in combination with strong grant support from the National Institute of Neurological Disorders and Stroke, will allow the Company to increase sales and marketing efforts for its software product, IdentEvent®, as well as to continue developing an innovative line of hardware-based brain monitors. In late 2009, the Company achieved a critical milestone by successfully obtaining FDA marketing clearance for its first product IdentEvent®, an EEG review suite with automated seizure detection used by clinicians as an adjuvant tool to aid in the diagnosis and management of patients suspected of having seizure disorders.

Leave a Reply

Your email address will not be published. Required fields are marked *

*